The project aims to develop a pharmacogenomic evaluation system for the treatment of breast cancer with aromatase inhibitors, using a new application designed by ROVI Laboratorios.
Its ultimate goal is the optimisation of drug delivery and release processes.
institutions and companies collaborating in the project
Adealis promotes the treatment of breast cancer with aromatase inhibitors
In order to successfully achieve the project’s objectives, Atrys Health collaborates with Laboratorios Rovi, Biomedadl, Vaxdyn, Hospital Vírgen del Rocío, the University of Granada, the University of Seville, the University of Cádiz, and Genyo.
The project is funded by the FEDER-INNTERCONECTA Programme for Andalusia.
